One of the most established academic health science networks in the country has appointed a director in a newly created role.

UCL Partners has recruited consultant neurologist Dr Charlie Davie who will take up the position in May while continuing with his clinical duties at the Royal Free London Foundation Trust.

Dr Davie had previously been a director of UCL Partners neuroscience programme.

UCL Partners was established in May 2013 and is built around six programmes covering cardiovascular disease, neurosciences, mental health, maternity and child health and co-morbidities and serves a population of 6 million across London, Hertfordshire, Essex and Bedfordshire.

In his new role, Dr Davie will work with the clinical-academic leads of these programmes to encourage joint working between them.

Dr Davie said: “I feel very privileged taking on this role within UCL Partners AHSN. We serve a population of 6 million people with the widest possible range of health and social care needs. I am looking forward to bringing together the expertise, innovation and enthusiasm which is present across our diverse range of partner organisations to improve health outcomes at scale and drive up economic growth.

“Healthcare models are having to change to meet the needs of our patients. I am committed to supporting partnership working and to facilitate innovative ways to improve the health and wellbeing of our communities.”

Professor David Fish, managing director of UCL Partners, said: “Dr Davie’s appointment completes the clinical-academic leadership team of the designated roles that we support across the whole patient pathway, giving us strength in depth to work in greater partnership and support our colleagues to truly make a difference to patients and populations.

“I am delighted to welcome Dr Davie to this new role and he brings significant experience and credibility to the partnership.”